Tofflon Science and Technology Group Co., Ltd. (SHE:300171)

China · Delayed Price · Currency is CNY

13.77

-0.66 (-4.57%)

Aug 24, 2026, 3:04 PM CST

-10.53% (1Y)

Market Cap	10.48B -10.5%
Revenue (ttm)	5.20B +3.3%
Net Income	207.76M +38.9%
EPS	0.27 +35.0%
Shares Out	760.85M
PE Ratio	50.99
Forward PE	28.59
Dividend	0.11 (0.80%)
Ex-Dividend Date	Jun 1, 2026

Volume	20,953,134
Open	14.40
Previous Close	14.43
Day's Range	13.68 - 14.54
52-Week Range	10.42 - 20.37
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:300171

Tofflon Science and Technology Group Co., Ltd. engages in the research, development, production, sales, and services of pharmaceutical equipment in China and internationally. The company offers technological research, including cell technology, complex preparation, injection, and OSD laboratory; instruments comprising cell therapy and nucleic acid drugs instruments, laboratory facilities, and table reactor; single use technology that include bioreactors, liquid distribution systems, sterile bags, process chromatography, membrane filtration syst... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1993

Employees 5,479

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300171

Full Company Profile

Financial Performance

In 2025, SHE:300171's revenue was 5.23 billion, an increase of 4.45% compared to the previous year's 5.01 billion. Earnings were 200.38 million, an increase of 3.24%.

Financial Statements